ARTICLE | Company News
Schering in-licenses Rho kinase inhibitor IP
September 20, 2004 7:00 AM UTC
Morphochem (Munich, Germany) and Migragen (Tuebingen, Germany) sold their joint rights to a patent application covering Rho kinase inhibitors to Schering (FSE:SCH; SHR). Migragen, which filed for inso...